You may have seen headlines recently claiming peptides like MOTS C or BPC 157 are back let's talk about what this means. In 2023, the FDA placed 19 commonly used peptides into Category FDA mulls compounding for peptides previously flagged over safety risks BioSpace boomrx #peptides #fda #compoundingpharmacy #clinicalmedicine #patientaccess BoomRX Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law